Health Reference Library

How do sun exposure and UV affect vitamin D and skin?

Last reviewed 2 May 2026

This entry is part of the Nutri Tailor Health Reference Library — cited research on supplements, nutrients and adjacent areas of health.

Summary

At UK latitudes (50-58 degrees N), no UVB-mediated vitamin D synthesis occurs from October to March (Webb 1988, PMID 2839537); supplementation 10 mcg/day October-March is required regardless of behaviour. April-September, brief unprotected midday exposure (10-30 minutes for fair skin, 3-6 times longer for darker skin) supports synthesis. Sunscreen blocks the same UVB that drives synthesis (Matsuoka 1987). NHS prioritises sunburn avoidance; year-round supplementation for darker-skinned, covered, indoor, over-65, and pregnant adults.

How it works

The UK sits at 50-58 degrees N (London around 51.5, Edinburgh around 55.9, Aberdeen around 57.1, Lerwick Shetland around 60.2). Practical UK vitamin D winter: October to March or early April depending on latitude. During this period UVB-mediated cutaneous vitamin D3 synthesis is effectively impossible regardless of time outdoors. The skin has intrinsic regulation against UVB-derived vitamin D toxicity: prolonged UV exposure photoisomerises previtamin D3 and vitamin D3 to inactive metabolites (lumisterol, tachysterol). Cutaneous synthesis self-limits regardless of exposure duration.

Effective dose

Older Holick-framework estimates of 10,000-25,000 IU from 10-20 minutes of summer midday sun are imprecise and vary substantially with skin type, surface area exposed, time of day, and latitude. NHS guidance does not specify a precise IU equivalent. Webb 2018 (Nutrients 10:497, "Colour counts: sunlight and skin type as drivers of vitamin D deficiency at UK latitudes") confirmed that standard sun exposure recommendations are sufficient for white European adults at UK latitudes but insufficient for South Asian origin adults. Clemens 1982 (Lancet 1:74-76, PMID 6119494) was the original demonstration of melanin attenuation of cutaneous vitamin D synthesis.

Forms compared

Reliance on diet alone for sufficiency is not realistic at UK latitudes between October and March. Tanning beds emitting UVB can produce vitamin D3 cutaneously but carry skin cancer risk and are not a recommended route. Oral supplementation October-March is the standard UK approach.

Timing

Body stores in adipose tissue can sustain 25(OH)D for weeks to months after summer exposure ends, which is why winter depletion is gradual rather than abrupt. Plasma 25(OH)D half-life is approximately 2-3 weeks; steady-state at any new daily oral dose reaches at 8-12 weeks. The British Association of Dermatologists and Cancer Research UK position aligns with the NHS practical message: avoid sunburn, cover up or seek shade between 11:00 and 15:00 in strong sun, use SPF30+ for prolonged exposure.

Safety profile

Cancer Research UK and British Association of Dermatologists emphasise: avoid sunburn, cover up or seek shade in strong midday sun, and use SPF30+ for prolonged exposure. The practical UK message: brief regular moderate exposure (April to September) is less concerning than rare intense holidays without protection. People at higher risk of skin cancer (fair skin, family history, prior non-melanoma skin cancer, immunosuppression) should weight skin cancer prevention more heavily and rely on supplementation for vitamin D needs year-round.

Special populations

Standard preventive dose is 10 mcg (400 IU) daily across these groups. Higher doses for specific clinical situations are specialist-supervision territory. Webb 2018 UK study confirmed that standard sun exposure recommendations are insufficient for South Asian origin adults at UK latitudes; year-round supplementation is the practical route. For housebound or residential-care adults, sun exposure is effectively zero year-round and supplementation is essential.

Interactions

Oral carotenoids have a modest photoprotective effect from inside the body. Stahl and Sies (PMID 23053552) have published systematic reviews. Mechanism: carotenoids accumulate in skin, quench reactive oxygen species, and reduce UV-induced lipid peroxidation; modestly raise minimal erythemal dose. Doses studied: beta-carotene 24 mg/day for 12 weeks; lycopene 16 mg/day for 10-12 weeks; astaxanthin 4 mg/day for 9 weeks. Effect sizes are modest (typically 15-30% reduction in UV-induced erythema markers). These are NOT a substitute for topical sunscreen; should be thought of as complementary.

Guideline positions

Primary US references: Endocrine Society 2024 Demay clinical practice guideline (PMID 38828931); Holick 2011 framework. The Webb 1988 paper (J Clin Endocrinol Metab 67(2):373-378, PMID 2839537) is the foundational evidence anchoring the UK vitamin D winter concept. Webb 2018 (Nutrients 10:497) extends this to UK skin-type-specific recommendations.

Practical framework

Sun-derived vitamin D toxicity is essentially impossible due to natural photoregulation. Sun exposure alone cannot maintain adequate 25(OH)D through winter regardless of behaviour. Oral carotenoids (beta-carotene, lycopene, astaxanthin) modestly support photoprotection from inside but do not replace topical sunscreen. Avoiding sunburn remains the priority for skin cancer risk reduction. This is a summary of published research, not personal health advice. Discuss any health or supplement decisions with a qualified healthcare professional, particularly during ongoing care, pregnancy, or with chronic conditions.

Common misconceptions

Claim: assuming UV exposure can produce vitamin D toxicity. The body photoisomerises previtamin D3 and vitamin D3 to inactive metabolites (lumisterol, tachysterol) once a threshold is reached, which is why hypervitaminosis D from sunlight is essentially unheard of even in lifeguards, outdoor workers, and equatorial populations. All clinically significant vitamin D toxicity reported is from oral supplementation or rare endogenous overproduction (granulomatous disease).

Who this matters for

This entry is relevant for the following groups, conditions, and medication contexts:

Sources

  1. NHS UK. Vitamin D — How to get enough vitamin D from sunlight. NHS UK (UK government).
  2. Scientific Advisory Committee on Nutrition (UK government) 2016. SACN Vitamin D and Health report. Scientific Advisory Committee on Nutrition (SACN, UK government).
  3. Webb AR, Kline L, Holick MF 1988. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. Journal of Clinical Endocrinology and Metabolism. PMID: 2839537 · DOI: 10.1210/jcem-67-2-373
  4. Webb AR, Kazantzidis A, Kift RC, Farrar MD, Wilkinson J, Rhodes LE 2018. Colour Counts: Sunlight and Skin Type as Drivers of Vitamin D Deficiency at UK Latitudes. Nutrients. PMID: 29642423 · DOI: 10.3390/nu10040457
  5. Clemens TL, Adams JS, Henderson SL, Holick MF 1982. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet. PMID: 6119494 · DOI: 10.1016/s0140-6736(82)90214-8
  6. Matsuoka LY, Ide L, Wortsman J, MacLaughlin JA, Holick MF 1987. Sunscreens suppress cutaneous vitamin D3 synthesis. Journal of Clinical Endocrinology and Metabolism. PMID: 3033008 · DOI: 10.1210/jcem-64-6-1165
  7. Cancer Research UK / British Association of Dermatologists. Sun, UV and cancer; Vitamin D guidance. Cancer Research UK / British Association of Dermatologists.
  8. Stahl W, Sies H 2012. beta-Carotene and other carotenoids in protection from sunlight. American Journal of Clinical Nutrition. PMID: 23053552 · DOI: 10.3945/ajcn.112.034819
  9. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM 2011. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism. PMID: 21646368 · DOI: 10.1210/jc.2011-0385

Related entries

Back to Vitamin D overview